Uliledlimab is an antibody designed to target CD73. The development pause will also allow I-Mab to allow data from an ongoing China-only randomised study conducted by its partner TJ Biopharma ...

Uliledlimab is an antibody designed to target CD73. The development pause will also allow I-Mab to allow data from an ongoing China-only randomised study conducted by its partner TJ Biopharma, to ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

A second asset is AB680 (quemliclustat), a small molecule CD73 antibody running a phase 3 trial in pancreatic cancer. There’s a third molecule, Etrumadenant, and two more, Casdatifan and ...

This is the second China-specific purchase by Sanofi in the last few months. In September, the French pharma acquired China rights to the CD73 antibody uliledlimab from I-Mab spinout TJ Biopharma.

Different types of antibodies are produced by your immune system. These five antibodies help fight disease by detecting viruses, bacteria, and other pathogens (disease-causing microorganisms) and ...